184 related articles for article (PubMed ID: 8345406)
1. C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis.
Burt AD
J Pathol; 1993 Jun; 170(2):105-14. PubMed ID: 8345406
[TBL] [Abstract][Full Text] [Related]
2. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
3. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
[TBL] [Abstract][Full Text] [Related]
4. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
Gressner AM; Bachem MG
Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
[TBL] [Abstract][Full Text] [Related]
5. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells.
Geremias AT; Carvalho MA; Borojevic R; Monteiro AN
BMC Gastroenterol; 2004 Dec; 4():30. PubMed ID: 15579200
[TBL] [Abstract][Full Text] [Related]
6. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis].
Casu A; Canepa M; Nanni G
Pathologica; 1994 Oct; 86(5):467-99. PubMed ID: 7739873
[TBL] [Abstract][Full Text] [Related]
7. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
9. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis.
Gressner AM; Bachem MG
Semin Liver Dis; 1990 Feb; 10(1):30-46. PubMed ID: 2186487
[TBL] [Abstract][Full Text] [Related]
10. Chronic liver injury, TGF-beta, and cancer.
Bissell DM
Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
[TBL] [Abstract][Full Text] [Related]
12. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
Arthur MJ; Mann DA; Iredale JP
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
[TBL] [Abstract][Full Text] [Related]
14. [Fibrogenesis and fibrolysis in the liver].
Herbst H; Schuppan D; Milani S
Verh Dtsch Ges Pathol; 1995; 79():15-27. PubMed ID: 8600680
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.
Parsons CJ; Bradford BU; Pan CQ; Cheung E; Schauer M; Knorr A; Krebs B; Kraft S; Zahn S; Brocks B; Feirt N; Mei B; Cho MS; Ramamoorthi R; Roldan G; Ng P; Lum P; Hirth-Dietrich C; Tomkinson A; Brenner DA
Hepatology; 2004 Nov; 40(5):1106-15. PubMed ID: 15389776
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
Herbst H; Wege T; Milani S; Pellegrini G; Orzechowski HD; Bechstein WO; Neuhaus P; Gressner AM; Schuppan D
Am J Pathol; 1997 May; 150(5):1647-59. PubMed ID: 9137090
[TBL] [Abstract][Full Text] [Related]
17. A cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver.
Gressner AM; Chunfang G
Verh Dtsch Ges Pathol; 1995; 79():1-14. PubMed ID: 8600672
[TBL] [Abstract][Full Text] [Related]
18. [The physiopathological mechanism of hepatic fibrosis].
Lauria V; Tariciotti G; Festuccia F; Attili AF
Minerva Gastroenterol Dietol; 1998 Sep; 44(3):149-58. PubMed ID: 16495897
[TBL] [Abstract][Full Text] [Related]
19. Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model.
Chang YZ; Yang L; Yang CQ
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):401-5. PubMed ID: 18693176
[TBL] [Abstract][Full Text] [Related]
20. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
